Nanobodies selective for oligomeric Tau species isolated from AD brain
Nanobodies selective for oligomeric Tau species isolated from AD brain
批准号:
8633097
负责人:
MICHAEL R SIERKS
金额:
$23.83万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-30 至 2015-06-30
关键词:
AgeAlzheimer&aposs DiseaseAmyloid beta-ProteinAntibodiesBindingBiological MarkersBrainCellsCellular StressDementiaDevelopmentDiagnosisDiagnosticDiagnostic testsDiseaseDisease ProgressionDonkeysEarly DiagnosisEventGenerationsGoalsHumanHuntington DiseaseImmunoglobulin FragmentsIn VitroLeadLewy Body DementiaMonitorMorphologyNeurodegenerative DisordersOnset of illnessParkinson DiseasePatientsPost-Translational Protein ProcessingProcessProteinsReagentSamplingSerumSourceSpecificityStagingStructureTauopathiesTestingTherapeuticTissue SampleTissuesToxic effectVariantalpha synucleinbasebrain tissuecell typedirect applicationdisorder controlextracellularhuman Huntingtin proteinhuman tissuein vivonanobodiesnovelprotein aggregateprotein aggregationprotein misfoldingprotein purificationpublic health relevancetau Proteinstau aggregationtau-1therapeutic targettooltreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Protein misfolding and aggregation is a common thread behind many neurodegenerative
diseases including Alzheimer's disease (AD), Lewy Body Dementia (LBD), and Parkinson's
disease (PD) among others. While each disease has been primarily associated with aggregation
of a specific protein; beta-amyloid (abeta) with AD, tau with AD and other tauopathies, alpha-
synuclein (a-syn) with PD and LBD, more than one protein is likely to misfold and aggregate in
brain tissue complicating diagnosis and treatment strategies. While all these proteins can form
fibrillar aggregates, they can also form a variety of different smaller soluble aggregate structures
as well. Studies indicate that small soluble protein aggregate forms are the relevant toxic
species in the various diseases rather than the fibrillar aggregates that serve as diagnostic
hallmarks. A variety of different intermediate oligomeric forms of each of these proteins can
exist in vitro and in vivo, and different aggregate forms can have different toxic effects on cells,
and may preferentially target different types of cells. Since cellular stress induced by misfolding
and aggregation of one protein such as abeta may well lead to misfolding and aggregation of
other proteins such as tau and a-syn, the presence of multiple misfolded proteins in different
diseases should be expected. Therefore characterizing which aggregated protein species are
correlated with different stages of each disease would greatly facilitate development of better
diagnostic and treatment strategies. We have generated several well characterized reagents
that specifically recognize different aggregated species of abeta and a-syn, and have
demonstrated that the reagents recognize aggregated species occurring in tissue from diseased
brains, but not healthy brains, and that the reagents can have disease specificity as well. Here
we will develop and test similar reagents for detecting specific forms of tau that are present in
AD brain tissue.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Purification and Characterization of a toxic AD associated intracellularly generated amyloid beta fragment
-
批准号:10511148
-
项目类别:
-
资助金额:$43.18万
-
财政年份:2022
-
负责人:MICHAEL R SIERKS
-
依托单位:
Protein variants as blood based biomarkers for diagnosing and staging AD
-
批准号:9977069
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2016
-
负责人:MICHAEL R SIERKS
-
依托单位:
Protein variants as blood based biomarkers for diagnosing and staging AD
-
批准号:9334047
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2016
-
负责人:MICHAEL R SIERKS
-
依托单位:
Nanobodies selective for oligomeric Tau species isolated from AD brain
-
批准号:8741902
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2013
-
负责人:MICHAEL R SIERKS
-
依托单位:
Developing Diagnostic Nanobodies Against Aggregated TDP-43 Species
-
批准号:8386058
-
项目类别:
-
资助金额:$24.55万
-
财政年份:2012
-
负责人:MICHAEL R SIERKS
-
依托单位:
Developing Diagnostic Nanobodies Against Aggregated TDP-43 Species
-
批准号:8517544
-
项目类别:
-
资助金额:$18.27万
-
财政年份:2012
-
负责人:MICHAEL R SIERKS
-
依托单位:
Intracellular tools to study specific misfolded protein variants in human disease
-
批准号:8307797
-
项目类别:
-
资助金额:$15.34万
-
财政年份:2011
-
负责人:MICHAEL R SIERKS
-
依托单位:
Intracellular tools to study specific misfolded protein variants in human disease
-
批准号:8191309
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2011
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6092779
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6372479
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6631468
-
项目类别:
-
资助金额:$25.6万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6509737
-
项目类别:
-
资助金额:$18.75万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位:
INHIBITING AGGREGATION WITH PHAGE DISPLAY ANTIBODIES
-
批准号:6685537
-
项目类别:
-
资助金额:$4.39万
-
财政年份:2000
-
负责人:MICHAEL R SIERKS
-
依托单位: